Wyeth 4Q Revenues: $5.8 billion (+10%) 4Q Earnings: $1.0 billion (+19%) FY Revenues: $22.4 billion (+10%) FY Earnings: $4.6 billion (+10%) Comments: Worldwide pharmaceutical sales increased 10% in both 4Q07 and FY07 due to higher sales of Enbrel, Prevnar, Nutrition products, Zosyn, Protonix and Effexor. The increase was offset, in part, by lower sales of Inderal LA due to generic competition. Effexor sales in the quarter were $968 million (+3%) and for the year were $3.8 billion (...